Heart drug may reveal why extra beats occur
NCT ID NCT03218137
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether adenosine, a drug that affects heart rhythm, can help identify the mechanism behind premature ventricular contractions (PVCs). About 100 adults scheduled for a standard heart procedure will receive adenosine or verapamil to see how their extra beats respond. The goal is to better understand the electrical cause of PVCs, not to treat them.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Adenosine
- What this could lead to
- If successful, this could help doctors better understand why PVCs happen and tailor treatments more precisely.
- What could go wrong
- This is a small, early mechanistic study, not a treatment trial. Results may not change clinical practice or benefit participants directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREMATURE VENTRICULAR CONTRACTION (PVC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Weill Cornell Medicine
RECRUITINGNew York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.